Parkinson's disease: in vivo metabolic changes in the frontal and parietal cortices in 6-OHDA treated rats during different periods

References

• Wu T, Hallett M. A functional MRI study of automatic movements in patients with Parkinson's disease. Brain 2005;128:2250–9.
   PubMed Web of Science ®Google Scholar
• Diukova A, Ware J, Smith JE, Separating neural and vascular effects of caffeine using simultaneous EEG-FMRI: differential effects of caffeine on cognitive and sensorimotor brain responses. Neuroimage 2012;62:239–49.
   PubMed Web of Science ®Google Scholar
• Tessa C, Lucetti C, Diciotti S, Hypoactivation of the primary sensorimotor cortex in de novo Parkinson's disease: a motor fMRI study under controlled conditions. Neuroradiology 2012;54:261–8.
   Google Scholar
• Frosini D, Pesaresi I, Cosottini M, Parkinson's disease and pathological gambling: results from a functional MRI study. Mov Disord 2010;25:2449–53.
   PubMed Web of Science ®Google Scholar
• Hou Z, Hong S, Sun B, Parkinson's disease: functional changes in frontal and parietal cortex using 18F-fluoro-deoxyglucose positron emission tomography/computed tomography. Neurology India 2010;58:53–7.
   Google Scholar
• Metarugcheep P, Hanchaiphiboolkul S, Viriyavejakul A, The usage of proton magnetic resonance spectroscopy in Parkinson's disease. J Med Assoc Thai 2012;95:949–52.
   Google Scholar
• Guevara CA, Blain CR, Stahl D, Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. Eur J Neurol 2010;17:1193–202.
   PubMed Web of Science ®Google Scholar
• Vaugoyeau M, Viel S, Assaiante C, Amblard B impaired vertical postural control and proprioceptive integration deficits in Parkinson's disease. Neuroscience 2007;146:852–63.
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 6th ed. Amsterdam: Elsevier; 2007.
   Google Scholar
• Hou Z, Lei H, Hong S, Functional changes in the frontal cortex in Parkinson's disease using a rat model. J Clin Neurosci 2010;17:628–33.
   PubMed Web of Science ®Google Scholar
• Carbon M, Felice Ghilardi M, Dhawan V, Eidelberg D. Correlates of movement initiation and velocity in Parkinson disease: a longitudinal PET study. Neuroimage 2007;34:361–70.
   Google Scholar
• Kikuchi A, Takeda A, Kimpara T, Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J Neurol Sci 2001;193:29–36.
   Google Scholar
• Sabatini U, Boulanouar K, Fabre N, Cortical motor reorganization in akinetic patients with Parkinson's disease: a functional MRI study. Brain 2000;123:394–403.
   PubMed Web of Science ®Google Scholar
• Clarke CE, Lowry M. Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy. Eur J Neurol 2000;7:661–5.
   PubMed Web of Science ®Google Scholar
• O'Neill J, Schuff N, Marks WJ Jr, 1H magnetic resonance spectroscopy and MRI of Parkinson's disease. Mov Disord 2002;17:917–27.
   PubMed Web of Science ®Google Scholar
• Wiguna T, Guerrero AP, Wibisono S, Effect of 12-week administration of 20-mg long-acting methylphenidate on Glu/Cr, NAA/Cr, Cho/Cr, and mI/Cr ratios in the prefrontal cortices of school-age children in Indonesia: a study using 1H magnetic resonance spectroscopy (MRS). Clin Neuropharmacol 2012;35:81–5.
   Web of Science ®Google Scholar
• Nilsen LH, Melø TM, Saether O, Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: a longitudinal in vivo (1) H MRS study. J Neurochem 2012;123:532–41.
   Google Scholar
• Nacewicz BM, Angelos L, Dalton KM, Reliable non-invasive measurement of human neurochemistry using proton spectroscopy with an anatomically defined amygdala-specific voxel. Neuroimage 2010;59:2548–59.
   Google Scholar
• Emir UE, Tuite PJ, Öz G. Elevated pontine and putamenal GABA levels in mild-moderate Parkinson disease detected by 7 tesla proton MRS. PLoS One 2012;7:e30918.
   Web of Science ®Google Scholar
• Hu MT, Taylor-Robinson SD, Chaudhuri KR, Evidence for cortical dysfunction in clinically non-demented patients with Parkinson's disease: a proton MR spectroscopy study. J Neurol Neurosurg Psychiatry 1999;67:20–6.
   Google Scholar
• Shinotoh H, Namba H, Yamaguchi M, Positron emission tomographic measurement of acetylcholinesterase activity reveals differential loss of ascending cholinergic systems in Parkinson's disease and progressive supranuclear palsy. Ann Neurol 1999;46:62–9.
   PubMed Web of Science ®Google Scholar
• Abe K, Terakawa H, Takanashi M, Proton magnetic resonance spectroscopy of patients with parkinsonism. Brain Res Bull 2000;52:589–95.
   PubMedGoogle Scholar
• Delli Pizzi S, Rossi C, Di Matteo V, Morphological and metabolic changes in the nigro-striatal pathway of synthetic proteasome inhibitor (PSI)-treated rats: a MRI and MRS study. PLoS One 2013;8(2):e56501.
   Google Scholar